Procoagulant factors and the risk of myocardial infarction in young women

European Journal of Haematology

Volumn 77, Issue 1, 2006, Pages 67-73

  Tanis, Bea ^a   Algra, Ale ^a,b   Van Der Graaf, Yolanda ^b   Helmerhorst, Frans ^a   Rosendaal, Frits ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Case control study; Coagulation factors; Myocardial infarction; Risk factor; Women

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; FIBRINOGEN; PROCOAGULANT; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD GROUP ABO SYSTEM; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADULT; BLOOD GROUP ANTIGENS; CASE-CONTROL STUDIES; FACTOR IX; FACTOR VIII; FACTOR XI; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTORS; THROMBOCYTOPENIA; VON WILLEBRAND FACTOR;

EID: 33745017133     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00656.x     Document Type: Article

References (46)

1. Koster T Blann AD Briët E Vandenbroucke JP Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995 345 : 152 155.
2. Kamphuisen PW Eikenboom JC Vos HL Pablo R Sturk A Bertina RM Rosendaal FR. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. Thromb Haemost 1999 81 : 680 683.
3. Kraaijenhagen RA in't Anker PS Koopman MM Reitsma PH Prins MH van den Ende A Büller HR. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000 83 : 5 9.
4. O'Donnell J Laffan M. Elevated plasma factor VIII levels - a novel risk factor for venous thromboembolism. Clin Lab 2001 47 : 1 6.
5. Kamphuisen PW Eikenboom JC Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001 21 : 731 738.
6. Meijers JC Tekelenburg WL Bouma BN Bertina RM Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000 342 : 696 701.
7. Van Hylckama Vlieg A van der Linden I Bertina RM Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000 95 : 3678 3682.
8. Balleisen L Bailey J Epping PH Schulte H van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 1985 54 : 475 479.
9. Conlan MG Folsom AR Finch A Davis CE Sorlie P Marcucci G Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993 70 : 380 385.
10. Tracy RP Bovill EG Yanez D Psaty BM Fried LP Heiss G Lee M Polak JF Savage PJ. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1995 15 : 1269 1279.
11. Woodward M Lowe GD Rumley A Tunstall-Pedoe H Philippou H Lane DA Morrison CE. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1997 97 : 785 797.
12. Medalie JH Levene C Papier C Goldbourt U Dreyfuss F Oron D Neufeld H Riss E. Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med 1971 285 : 1348 1353.
13. Meade TW Cooper JA Stirling Y Howarth DJ Ruddock V Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994 88 : 601 607.
14. Rumley A Lowe GD Sweetnam PM Yarnell JW Ford RP. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol 1999 105 : 110 116.
15. Gill JC Endres-Brooks J Bauer PJ Marks WJ Jr. Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987 69 : 1691 1695.
16. Caekebeke-Peerlinck KM Koster T Briët E. Bleeding time, blood groups and von Willebrand factor. Br J Haematol 1989 73 : 217 220.
17. Cucuianu MP Cristea A Roman S Rus H Missits I Pechet L. Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction. Thromb Res 1983 30 : 487 497.
18. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986 314 : 488 500.
19. Meade TW Mellows S Brozovic M Miller GJ Chakrabarti RR North WR Haines AP Stirling Y Imeson JD Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986 2 : 533 537.
20. Jansson JH Nilsson TK Johnson O. Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991 66 : 351 355.
21. Thompson SG Kienast J Pyke SD Haverkate F van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995 332 : 635 641.
22. Folsom AR Wu KK Rosamond WD Sharrett AR Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997 96 : 1102 1108.
23. Rosendaal FR Briët E Stibbe J van Herpen G Leuven JA Hofman A Vandenbroucke JP. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990 75 : 525 530.
24. Triemstra M Rosendaal FR Smit C van der Ploeg HM Briët E. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1995 123 : 823 827.
25. Ridker PM Buring JE Shih J Matias M Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998 98 : 731 733.
26. Ridker PM Glynn RJ Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998 97 : 2007 2011.
27. Doggen CJ Berckmans RJ Sturk A Manger Cats V Rosendaal FR. C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men. J Intern Med 2000 248 : 406 414.
28. Davie EW Fujikawa K Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991 30 : 10363 10370.
29. Bouma BN van den Borne PA Meijers JC. Factor XI and protection of the fibrin clot against lysis - a role for the intrinsic pathway of coagulation in fibrinolysis. Thromb Haemost 1998 80 : 24 27.
30. Bouma BN Meijers JC. Role of blood coagulation factor XI in downregulation of fibrinolysis. Curr Opin Hematol 2000 7 : 266 272.
31. Tanis BC van den Bosch MA Kemmeren JM Manger Cats V Helmerhorst FM Algra A van der Graaf Y Rosendaal FR. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001 345 : 1787 1793.
32. Jick H Dinan B Herman R Rothman KJ. Myocardial infarction and other vascular diseases in young women. Role of estrogens and other factors. JAMA 1978 240 : 2548 2552.
33. Whincup PH Cook DG Phillips AN Shaper AG. ABO blood group and ischaemic heart disease in British men. BMJ 1990 300 : 1679 1682.
34. Sakai H Goto S Kim JY Aoki N Abe S Ichikawa N Yoshida M Nagaoka Y Handa S. Plasma concentration of von Willebrand factor in acute myocardial infarction. Thromb Haemost 2000 84 : 204 209.
35. Lim HS Chong AY Freestone B Blann AD Lip GY. The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease. Diab Med 2005 22 : 249 255.
36. Spencer CG Gurney D Blann AD Beevers DG Lip GY. ASCOT Steering Committee, Anglo Scandinavian Cardiac Outcome Trial. Hypertension 2002 40 : 61 66.
37. O'Donnell J Mumford AD Manning RA Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 2000 83 : 10 13.
38. Souto JC Almasy L Muniz-Diaz E et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000 20 : 2024 2028.
39. Rosendaal FR Bovill EG. Heritability of clotting factors and the revival of the prothrombotic state. Lancet 2002 359 : 638 639.
40. Montalescot G Philippe F Ankri A et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. Circulation 1998 98 : 294 299.
41. Rosendaal FR Varekamp I Smit C Brocker-Vriends AH van Dijck H Vandenbroucke JP Hermans J Suurmeijer TP Briët E. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989 71 : 71 76.
42. Šrámek A Kriek M Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003 362 : 351 354.
43. Salomon O Steinberg DM Dardik R Rosenberg N Zivelin A Tamarin I Ravid B Berliner S Seligsohn U. Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost 2003 1 : 658 661.
44. Ridker PM Hennekens CH Buring JE Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000 342 : 836 843.
45. Jager A van Hinsbergh VW Kostense PJ Emeis JJ Yudkin JS Nijpels G Dekker JM Heine RJ Bouter LM Stehouwer CD. Von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol 1999 19 : 3071 3078.
46. Prandoni P Bilora F Marchiori A Bernardi E Petrobelli F Lensing AW Prins MH Girolami A. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003 348 : 1435 1441.